IMC Chicago’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Sell
82,518
-51,890
-39% -$1.19M ﹤0.01% 3220
2026
Q1
$2.96M Buy
134,408
+85,485
+175% +$1.49M ﹤0.01% 2234
2025
Q4
$577K Buy
48,923
+8,196
+20% +$105K ﹤0.01% 3381
2025
Q3
$645K Sell
40,727
-12,917
-24% -$187K ﹤0.01% 3008
2025
Q2
$614K Buy
+53,644
New +$604K ﹤0.01% 2751
2025
Q1
Sell
-98,377
Closed -$1.63M 3142
2024
Q4
$1.66M Buy
+98,377
New +$1.91M ﹤0.01% 2002
2024
Q2
Sell
-21,953
Closed -$575K 2639
2024
Q1
$576K Buy
+21,953
New +$625K ﹤0.01% 1982

Other funds holding CC

IMC Chicago's CC Position: Q2 2026 in Review

IMC Chicago reduced its Chemours (CC) stake by 39% in Q2 2026, selling an estimated $1.19M and leaving 82,518 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3220.

IMC Chicago first reported a position in CC in Q1 2024 and has held it in 7 quarters since. The position peaked at $2.96M in Q1 2026. 232 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • IMC Chicago held 82,518 shares of Chemours worth $1.69M as of Q2 2026.
  • IMC Chicago sold 51,890 Chemours shares in Q2 2026, an estimated $1.19M.
  • Chemours made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3220 holding.
  • IMC Chicago first reported a position in Chemours in Q1 2024 and has held it in 7 quarters since.
  • IMC Chicago's Chemours position peaked at $2.96M in Q1 2026.
  • 232 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.